Odomzo Approved for Recurring Basal Cell Carcinoma

Title: Odomzo Approved for Recurring Basal Cell CarcinomaCategory: Health NewsCreated: 7/24/2015 12:00:00 AMLast Editorial Review: 7/27/2015 12:00:00 AM

http://www.medicinenet.com/guide.asp?s=rss&a=189669&k=Cancer_General

Source: MedicineNet Cancer General - July 27, 2015 Category: Cancer & Oncology Source Type: news